These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 8205642)

  • 21. A low-cost, community-based measles outbreak investigation with follow-up action.
    Weeks RM; Barenzi JF; Wayira JR
    Bull World Health Organ; 1992; 70(3):317-21. PubMed ID: 1638659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.
    Markowitz LE; Sepulveda J; Diaz-Ortega JL; Valdespino JL; Albrecht P; Zell ER; Stewart J; Zarate ML; Bernier RH
    N Engl J Med; 1990 Mar; 322(9):580-7. PubMed ID: 2304505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of mass measles campaigns among children less than 5 years old in Uganda.
    Nanyunja M; Lewis RF; Makumbi I; Seruyange R; Kabwongera E; Mugyenyi P; Talisuna A
    J Infect Dis; 2003 May; 187 Suppl 1():S63-8. PubMed ID: 12721893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of nationwide measles vaccination campaign among children aged 9 months to 14 years, Zimbabwe, 1998-2001.
    Munyoro MN; Kufa E; Biellik R; Pazvakavambwa IE; Cairns KL
    J Infect Dis; 2003 May; 187 Suppl 1():S91-6. PubMed ID: 12721898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies to improve immunization services in urban Africa.
    Cutts FT
    Bull World Health Organ; 1991; 69(4):407-14. PubMed ID: 1934234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A primary health care baseline survey in a rural district in Zambia.
    Trykker H; Simwambana A; Kantu K; Eberhard M
    Afr J Med Med Sci; 1994 Jun; 23(2):147-51. PubMed ID: 7625303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress toward measles control - African region, 2001-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(37):1036-41. PubMed ID: 19779399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Worldwide measles prevention.
    Orenstein WA; Markowitz LE; Atkinson WL; Hinman AR
    Isr J Med Sci; 1994; 30(5-6):469-81. PubMed ID: 8034506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress toward global measles control and elimination, 1990-1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Sep; 46(38):893-7. PubMed ID: 9315780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress in measles control--Zambia, 1999-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Jun; 54(23):581-4. PubMed ID: 15959454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementation of a mass measles campaign in central Afghanistan, December 2001 to May 2002.
    Dadgar N; Ansari A; Naleo T; Brennan M; Salama P; Sadozai N; Golaz A; Lievano F; Jafari H; Mubarak M; Hoekstra E; Paganini A; Feroz F
    J Infect Dis; 2003 May; 187 Suppl 1():S186-90. PubMed ID: 12721912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Migration as a risk factor for measles after a mass vaccination campaign, Burkina Faso, 2002.
    Yaméogo KR; Perry RT; Yaméogo A; Kambiré C; Kondé MK; Nshimirimana D; Kezaala R; Hersh BS; Cairns KL; Strebel P
    Int J Epidemiol; 2005 Jun; 34(3):556-64. PubMed ID: 15659463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of protection afforded by single measles vaccination and late revaccination schedules.
    Marufu T; Siziya S; Tshimanga M; Murugasampillay S; Mason E
    East Afr Med J; 1997 Dec; 74(12):777-9. PubMed ID: 9557421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measles in Jordan: a prototype of the problems with measles in developing countries.
    Khuri-Bulos NA
    Pediatr Infect Dis J; 1995 Jan; 14(1):22-6. PubMed ID: 7715984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the protection afforded measles vaccinees the same in children of all age groups?
    Marufu T; Murugasampillary S; Siziya S; Manyame B; Silape-Marufu Z; Xaba E; Zimbizi P; Ruwodo C; Mudyarabikwa O; Matchaba-Hove R
    Cent Afr J Med; 1995 May; 41(5):144-7. PubMed ID: 7627998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measles control in developing and developed countries: the case for a two-dose policy.
    Tulchinsky TH; Ginsberg GM; Abed Y; Angeles MT; Akukwe C; Bonn J
    Bull World Health Organ; 1993; 71(1):93-103. PubMed ID: 8440043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experience in global measles control, 1990-2001.
    Henao-Restrepo AM; Strebel P; John Hoekstra E; Birmingham M; Bilous J
    J Infect Dis; 2003 May; 187 Suppl 1():S15-21. PubMed ID: 12721887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interruption of indigenous measles transmission in Bolivia since October 2000.
    Quiroga R; Barrezueta O; Venczel L; Halkyer P; Gil F; Machicao E; Landaverde M; Quiñonez A; Izurieta H
    J Infect Dis; 2003 May; 187 Suppl 1():S121-6. PubMed ID: 12721902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.